{
  "id": [
    "PMC7559676"
  ],
  "source": [
    "PMC"
  ],
  "pmcid": [
    "PMC7559676"
  ],
  "fullTextIdList": [
    {
      "fullTextId": [
        "PMC7559676"
      ]
    }
  ],
  "title": [
    "Role of monoclonal antibody drugs in the treatment of COVID-19"
  ],
  "authorString": [
    "Ucciferri C, Vecchiet J, Falasca K."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Ucciferri C"
          ],
          "firstName": [
            "Claudio"
          ],
          "lastName": [
            "Ucciferri"
          ],
          "initials": [
            "C"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                ""
              ]
            }
          ]
        },
        {
          "fullName": [
            "Vecchiet J"
          ],
          "firstName": [
            "Jacopo"
          ],
          "lastName": [
            "Vecchiet"
          ],
          "initials": [
            "J"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                ""
              ]
            }
          ]
        },
        {
          "fullName": [
            "Falasca K"
          ],
          "firstName": [
            "Katia"
          ],
          "lastName": [
            "Falasca"
          ],
          "initials": [
            "K"
          ],
          "authorAffiliationsList": [
            {
              "authorAffiliation": [
                ""
              ]
            }
          ]
        }
      ]
    }
  ],
  "dataLinksTagsList": [
    {
      "dataLinkstag": [
        "supporting_data"
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "19"
      ],
      "volume": [
        "8"
      ],
      "journalIssueId": [
        "3041125"
      ],
      "dateOfPublication": [
        "2020 Oct"
      ],
      "monthOfPublication": [
        "10"
      ],
      "yearOfPublication": [
        "2020"
      ],
      "printPublicationDate": [
        "2020-10-01"
      ],
      "journal": [
        {
          "title": [
            "World journal of clinical cases"
          ],
          "ISOAbbreviation": [
            "World J Clin Cases"
          ],
          "medlineAbbreviation": [
            "World J Clin Cases"
          ],
          "NLMid": [
            "101618806"
          ],
          "ISSN": [
            "2307-8960"
          ],
          "ESSN": [
            "2307-8960"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2020"
  ],
  "pageInfo": [
    "4280-4285"
  ],
  "abstractText": [
    "Currently clinicians all around the world are experiencing a pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical presentation of this pathology includes fever, dry cough, fatigue and acute respiratory distress syndrome that can lead to death infected patients. Current studies on coronavirus disease 2019 (COVID-19) continue to highlight the urgent need for an effective therapy. Numerous therapeutic strategies have been used until now but, to date, there is no specific effective treatment for SARS-CoV-2 infection. Elevated inflammatory cytokines have been reported in patients with COVID-19. Evidence suggests that elevated cytokine levels, reflecting a hyperinflammatory response secondary to SARS-CoV-2 infection, are responsible for multi-organ damage in patients with COVID-19. For these reason, numerous randomized clinical trials are currently underway to explore the effectiveness of biopharmaceutical drugs, such as, interleukin-1 blockers, interleukin-6 inhibitors, Janus kinase inhibitors, in COVID-19. The aim of the present paper is to briefly summarize the pathogenetic rationale and the state of the art of therapeutic strategy blocking hyperinflammation."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Undetermined"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "review-article",
        "Review",
        "Journal Article"
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Tocilizumab",
        "Canakinumab",
        "Anakinra",
        "Ruxolitinib",
        "Tofacitinib",
        "Siltuximab",
        "Baricitinib",
        "Sarilumab",
        "Clazakizumab"
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "PubMedCentral"
          ],
          "url": [
            "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559676/?tool=EBI"
          ]
        },
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "PubMedCentral"
          ],
          "url": [
            "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559676/pdf/?tool=EBI"
          ]
        },
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7559676"
          ]
        },
        {
          "availability": [
            "Free"
          ],
          "availabilityCode": [
            "F"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "https://europepmc.org/articles/PMC7559676?pdf=render"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "Y"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "0"
  ],
  "hasData": [
    "Y"
  ],
  "hasReferences": [
    "N"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "license": [
    "cc by-nc"
  ],
  "authMan": [
    "N"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "nihAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "Y"
  ],
  "tmAccessionTypeList": [
    {
      "accessionType": [
        "nct"
      ]
    }
  ],
  "dateOfCreation": [
    "2020-10-21"
  ],
  "firstIndexDate": [
    "2020-10-21"
  ],
  "fullTextReceivedDate": [
    "2020-10-21"
  ],
  "dateOfRevision": [
    "2020-10-21"
  ],
  "electronicPublicationDate": [
    "2020-10-06"
  ],
  "firstPublicationDate": [
    "2020-10-06"
  ]
}